Aimmune Therapeutics Inc 1 year target
What is the 1 year target of Aimmune Therapeutics Inc?
The 1 year target of Aimmune Therapeutics Inc is $33 +17.46%
What is the definition of 1 year target?
1 year target is a predicted stock price a year from now.
= average of analyst price targets
One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.
1 year target of companies in the Health Care sector on NASDAQ compared to Aimmune Therapeutics Inc
Companies with 1 year target similar to Aimmune Therapeutics Inc
- Sleep Country Canada has 1 year target of CAD$33 -4.44%
- Elanco Animal Health Inc has 1 year target of $33 +130.18%
- Riskified has 1 year target of $33 +627.73%
- IDP Education has 1 year target of AUD$33 +107.99%
- innogy SE has 1 year target of €33 -23.53%
- Quebecor has 1 year target of CAD$33 -2.31%
- Aimmune Therapeutics Inc has 1 year target of $33 +17.46%
- Bilfinger SE has 1 year target of €33 -27.12%
- Synchrony has 1 year target of $33 -27.09%
- Hexaom S.A has 1 year target of €33 +70.61%
- BBX Capital has 1 year target of $34 +150.19%
- Qualigen Therapeutics has 1 year target of $34 +20,837.50%
- Columbia Banking System has 1 year target of $34 +42.67%